바이오모아 (BioMoa) — ADC · Antibody

9268프로그램 35FDA 승인

4오늘 방문

572누적 방문

8122갱신 대기 S–CData Tier S/A/B차세대 1068HER2 breast 5456Antibody 2744CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

CGTBiologicstaleKara Yakhteh Tajhiz Azma CompanyPhase 2

anti-CD19 CAR T cell therapy (anti-CD19 CAR T cell therapy)

Relapse/Refractory B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

효능 ORR 94%임상시험 30상태 RECRUITING

AntibodystaleRochePreclinical

trastuzumab (Herceptin, Pertuzumab Plus Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2

효능 ORR 69.3%임상시험 30상태 ACTIVE

AntibodystaleRochePreclinical

trastuzumab (Herceptin, Pyrotinib Plus Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2

임상시험 30상태 ACTIVE

ADCBiologicstaleChinese Academy of Medical Scie…Preclinical

Maintenance therapy-chidamide (Maintenance therapy-chidamide)

CD30+ Peripheral T-cell Lymphoma · CD30

#CD30#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2

임상시험 30상태 RECRUITING

ADCBiologicstaleLaura Huppert, MD, BAPhase 2

Amiloride (Amiloride)

HER2 Low Breast Carcinoma; Triple Negative Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 30상태 RECRUITING

AntibodystaleTG Therapeutics, Inc.Phase 2

Ublituximab (Ublituximab)

Non-Hodgkins Lymphoma; B-cell Lymphoma · B-Cell Lymphoma

#B-CellLymphoma#Antibody#Phase2#항체#면역항체+4

효능 ORR 84.4%임상시험 30상태 ACTIVE

ADCBiologicstalePuma Biotechnology, Inc.Phase 2

HKI-272 (HKI-272)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 74.8%임상시험 30상태 ACTIVE

AntibodystaleJanssenApproved

teclistamab OR talquetamab OR elranatamab OR linvoseltamab (teclistamab OR talquetamab OR elranatamab OR linvoseltamab)

Waldenstrom Macroglobulinaemia; Multiple Myeloma · Waldenstrom Macroglobulinaemia

#WaldenstromMacroglobulinaemia#Antibody#Approved#항체#면역항체+3

효능 ORR 50%임상시험 30상태 RECRUITING

ADCBiologicstaleSerum Life Science Europe GmbHPhase 2

Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine)

Non-muscle Invasive Bladder Cancer; HER-2 Protein Overexpression · Non-muscle Invasive Bladder Cancer

#Non-muscleInvasiveBladderCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 30상태 RECRUITING

AntibodystaleRochePreclinical

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2

효능 ORR 91.8%임상시험 30상태 ACTIVE

ADCBiologicstaleAstraZenecaApproved

Dexamethasone mouthwash (Dexamethasone mouthwash)

Stomatitis · Stomatitis

#Stomatitis#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1

임상시험 30상태 RECRUITING

AntibodystaleEli Lilly and CompanyPhase 3

Mirikizumab (Mirikizumab)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase3#항체#면역항체+2

효능 ORR 0.115%임상시험 30상태 DISCONTINUED

AntibodystaleRochePhase 2

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2

효능 ORR 50%임상시험 30상태 ACTIVE

AntibodystaleADC TherapeuticsPhase 3

Loncastuximab tesirine (Loncastuximab tesirine)

Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 3b Follicular Lymphoma · B-cell Non Hodgkin Lymphoma

#B-cellNonHodgkinLymphoma#Antibody#Phase3#항체#면역항체+4

효능 ORR 94.1%임상시험 30상태 RECRUITING

AntibodyTang-Du Hospitalvedotin (RC48) in combinati…Phase 2

Adebrelimab combined with Apatinib (Adebrelimab combined with Apatinib)

SCLC · SCLC

#SCLC#Antibody#Phase2#항체#면역항체+4

임상시험 30상태 RECRUITING

AntibodystaleBristol Myers SquibbPhase 1

nivolumab (Opdivo, Gemcitabine/Carboplatin/Nivolumab)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#Antibody#Phase1#항체#면역항체+2

효능 ORR 69.6%임상시험 30상태 ACTIVE

AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, Durvalumab plus Olaparib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4

효능 ORR 55.1%임상시험 30상태 RECRUITING

AntibodystaleRochePhase 2

Bendamustine + Rituximab (Bendamustine + Rituximab)

Marginal Zone Lymphoma(MZL) · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+3

효능 ORR 95%임상시험 30상태 RECRUITING

ADCBiologicstaleCullinan Therapeutics Inc.Phase 1

Dato-DXd (Datopotamab deruxtecan-dlnk, Datopotamab deruxtecan-dlnk (Dato-DXd))

Advanced Solid Tumor; NSCLC · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 74%임상시험 30상태 RECRUITING

AntibodystaleRegeneronPhase 2

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept IVT)

Neovascular (Wet) Age-Related Macular Degeneration · Diabetic Macular Edema

#DiabeticMacularEdema#Antibody#Phase2#항체#면역항체+3

효능 ORR 11.4%임상시험 30상태 RECRUITING

AntibodystaleGrupo Español de Linfomas y Tra…Phase 2

Zevalin (Ibritumomab Tiuxetan, Ibritumomab Tiuxetan (Zevalin))

Non-Hodgkin Lymphoma · Lymphoma

#Lymphoma#Antibody#Phase2#항체#면역항체+3

효능 ORR 16%임상시험 30상태 ACTIVE

AntibodystaleBiogenPhase 2

90-Y-ibritumomab tiuxetan (90-Y-ibritumomab tiuxetan)

Lymphoma · Lymphoma

#Lymphoma#Antibody#Phase2#항체#면역항체+2

효능 ORR 89%임상시험 30상태 ACTIVE

ADCBiologicstaleAstraZenecaPhase 2

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

효능 ORR 64.3%임상시험 30상태 RECRUITING

AntibodystaleGilead SciencesPhase 2

Magrolimab (Magrolimab)

Solid Tumor; Colorectal Cancer · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+4

효능 ORR 66.7%임상시험 30상태 DISCONTINUED

AntibodyRochevedotin and anti-CD19 chime…Phase 2

Acalabrutinib combination with Rituximab (Acalabrutinib combination with Rituximab)

Mantle-cell Lymphoma · Mantle-cell Lymphoma

#Mantle-cellLymphoma#Antibody#Phase2#항체#면역항체+4

효능 ORR 66.4%임상시험 30상태 RECRUITING

27 / 167 페이지

← 이전 다음 →

전체 9,268개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 4 / 572

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

anti-CD19 CAR T cell therapy (anti-CD19 CAR T cell therapy)

trastuzumab (Herceptin, Pertuzumab Plus Trastuzumab)

trastuzumab (Herceptin, Pyrotinib Plus Trastuzumab)

Maintenance therapy-chidamide (Maintenance therapy-chidamide)

Amiloride (Amiloride)

Ublituximab (Ublituximab)

HKI-272 (HKI-272)

teclistamab OR talquetamab OR elranatamab OR linvoseltamab (teclistamab OR talquetamab OR elranatamab OR linvoseltamab)

Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine)

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

Dexamethasone mouthwash (Dexamethasone mouthwash)

Mirikizumab (Mirikizumab)

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Loncastuximab tesirine (Loncastuximab tesirine)

Adebrelimab combined with Apatinib (Adebrelimab combined with Apatinib)

nivolumab (Opdivo, Gemcitabine/Carboplatin/Nivolumab)

durvalumab (Imfinzi, Durvalumab plus Olaparib)

Bendamustine + Rituximab (Bendamustine + Rituximab)

Dato-DXd (Datopotamab deruxtecan-dlnk, Datopotamab deruxtecan-dlnk (Dato-DXd))

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept IVT)

Zevalin (Ibritumomab Tiuxetan, Ibritumomab Tiuxetan (Zevalin))

90-Y-ibritumomab tiuxetan (90-Y-ibritumomab tiuxetan)

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Magrolimab (Magrolimab)

Acalabrutinib combination with Rituximab (Acalabrutinib combination with Rituximab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

anti-CD19 CAR T cell therapy (anti-CD19 CAR T cell therapy)

trastuzumab (Herceptin, Pertuzumab Plus Trastuzumab)

trastuzumab (Herceptin, Pyrotinib Plus Trastuzumab)

Maintenance therapy-chidamide (Maintenance therapy-chidamide)

Amiloride (Amiloride)

Ublituximab (Ublituximab)

HKI-272 (HKI-272)

teclistamab OR talquetamab OR elranatamab OR linvoseltamab (teclistamab OR talquetamab OR elranatamab OR linvoseltamab)

Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine)

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

Dexamethasone mouthwash (Dexamethasone mouthwash)

Mirikizumab (Mirikizumab)

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Loncastuximab tesirine (Loncastuximab tesirine)

Adebrelimab combined with Apatinib (Adebrelimab combined with Apatinib)

nivolumab (Opdivo, Gemcitabine/Carboplatin/Nivolumab)

durvalumab (Imfinzi, Durvalumab plus Olaparib)

Bendamustine + Rituximab (Bendamustine + Rituximab)

Dato-DXd (Datopotamab deruxtecan-dlnk, Datopotamab deruxtecan-dlnk (Dato-DXd))

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Aflibercept IVT)

Zevalin (Ibritumomab Tiuxetan, Ibritumomab Tiuxetan (Zevalin))

90-Y-ibritumomab tiuxetan (90-Y-ibritumomab tiuxetan)

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Magrolimab (Magrolimab)

Acalabrutinib combination with Rituximab (Acalabrutinib combination with Rituximab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

anti-CD19 CAR T cell therapy (anti-CD19 CAR T cell therapy)

trastuzumab (Herceptin, Pertuzumab Plus Trastuzumab)

trastuzumab (Herceptin, Pyrotinib Plus Trastuzumab)

Maintenance therapy-chidamide (Maintenance therapy-chidamide)

Amiloride (Amiloride)

Ublituximab (Ublituximab)

HKI-272 (HKI-272)

teclistamab OR talquetamab OR elranatamab OR linvoseltamab (teclistamab OR talquetamab OR elranatamab OR linvoseltamab)

Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine)

trastuzumab (Herceptin, Docetaxel combined with Trastuzumab±Pertuzumab)

Dexamethasone mouthwash (Dexamethasone mouthwash)

Mirikizumab (Mirikizumab)

trastuzumab (Herceptin, Trastuzumab, Lapatinib)

Loncastuximab tesirine (Loncastuximab tesirine)

Adebrelimab combined with Apatinib (Adebrelimab combined with Apatinib)

nivolumab (Opdivo, Gemcitabine/Carboplatin/Nivolumab)